Entering text into the input field will update the search result below

TELA Bio launches SiteGuard for use in plastic reconstructive surgery

Mar. 03, 2022 8:20 AM ETTELA Bio, Inc. (TELA)By: Ravikash, SA News Editor

concentrated professional surgical doctor team operating surgery a patient in the operating room at the hospital. healthcare and medical concept."n

Gumpanat/iStock via Getty Images

  • TELA Bio (NASDAQ:TELA) launched its SiteGuard No Rinse Antimicrobial Solution for use in plastic reconstructive surgery.
  • The company said SiteGuard uses Next Science's proprietary XBIO Technology that supports surgical site and post-operative infection control by addressing

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About TELA

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TELA Bio, Inc.
Xtant Medical Holdings, Inc.
VolitionRx Limited
Rockwell Medical, Inc.
InspireMD, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.